|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Life Therapeutics, Ltd. (LFE.AX), a biotechnology company which offers a complete cycle of plasma derived products and services. |
|---|---|
| Transferring Party | Pyramid Biological, a plasma and biodiagnostic supplier. |
| Sector | Diagnostics |
| Date | July 15, 2005 |
| Analysis The acquisition increases Life's plasma collection capacity and increases its share of plasma markets. Consists of $13 million plus assumption of $7 million debt. An additional $5 million is subject to milestones. The forecast of projected sales for US fiscal year 2006 is $54.8 million with a projected earnings of $7.4 million EBITDA. Life Therapeutics expects to achieve significant cost savings thru synergies. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |